traceability and uncertaintyobjednavky.roche-diagnostics.cz/objednavky/info/...cholesterol chod-pap...

9
TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2 Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.) Roche Diagnostics GmbH März 2018 Routine Method Hitachi Systems ACN Reference Method Reference Material Selected Measurement Procedure Assigned Value Uncertainty 1 Unit ATRYP Antitrypsin alpha 1 immunoturbidimetric 048 ERM-DA470k/IFCC 9 136 1.36 1.84 0.0184 mg/dL g/L GPROT Acid glycoprotein alpha 1 immunoturbidimetric 229 CRM 470 2 88.5 0.885 1.39 0.0139 mg/dL g/L ACP Acid phosphatase total 1-naphthyl phosphate 021 Roche reagent, manual measurement 0.720 43.1 0.00703 0.421 µkat/L U/L ACP-NPP Acid phosphatase, non-prostatic 1-naphthyl phosphate(Inhib.:tartrate) 022 Roche reagent, manual measurement 0.418 25.0 0.00805 0.482 µkat/L U/L ACP-P Acid phosphatise, prostatic 1-naphthyl phosphate(Inhib.:tartrate) - calculated 0.302 18.1 0.0107 0.640 µkat/L U/L ALB Albumin BCG plus 413 ERM-DA470k/IFCC 9 4830 48.3 52.9 0.529 mg/dL g/L ALB Albumin BCP 760 ERM-DA470k/IFCC 9 4500 45.0 46.0 0.460 mg/dL g/L ALB2 Albumin immunoturbidimetric 412 ERM-DA470k/IFCC 9 4.42 44.2 0.0668 0.668 g/dL g/L ALP Alkaline phosphatase IFCC liquid 158 Original formulation IFCC 5 (Tietz, 1983), manual measurement 202 1.48 U/L ALP Alkaline phosphatase IFCC liquid 158 Original formulation IFCC 5 (Schumann, 2011), manual measurement 230 2.16 U/L ALP Alkaline phosphatase opt. (DGKC) 683 Roche reagent, manual measurement 413 4.19 U/L ALT Alanine aminotransferase IFCC with pyridoxal phosphate 684 Original formulation IFCC 5 (2002), manual measurement 1.94 116 0.0153 0.917 µkat/L U/L

Upload: tranduong

Post on 25-May-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

ATRYP

Antitrypsin alpha 1

immunoturbidimetric

048 ERM-DA470k/IFCC9 136

1.36

1.84

0.0184

mg/dL

g/L

GPROT

Acid glycoprotein alpha 1

immunoturbidimetric

229 CRM 4702 88.5

0.885

1.39

0.0139

mg/dL

g/L

ACPAcid phosphatase total

1-naphthyl phosphate

021Roche reagent, manual measurement

0.72043.1

0.007030.421

µkat/LU/L

ACP-NPPAcid phosphatase, non-prostatic

1-naphthyl phosphate(Inhib.:tartrate)

022Roche reagent, manual measurement

0.41825.0

0.008050.482

µkat/LU/L

ACP-PAcid phosphatise, prostatic

1-naphthyl phosphate(Inhib.:tartrate)

- calculated0.30218.1

0.01070.640

µkat/LU/L

ALB

Albumin BCG plus

413 ERM-DA470k/IFCC9 4830

48.3

52.9

0.529

mg/dL

g/L

ALB

Albumin BCP

760 ERM-DA470k/IFCC9 4500

45.0

46.0

0.460

mg/dL

g/L

ALB2

Albumin immunoturbidimetric

412 ERM-DA470k/IFCC9 4.42

44.2

0.0668

0.668

g/dL

g/L

ALP

Alkaline phosphataseIFCC liquid

158Original formulation

IFCC5 (Tietz, 1983),

manual measurement

202 1.48 U/L

ALP

Alkaline phosphatase

IFCC liquid

158Original formulation

IFCC5 (Schumann, 2011),

manual measurement

230 2.16 U/L

ALP

Alkaline phosphatase

opt. (DGKC)

683Roche reagent, manual

measurement413 4.19 U/L

ALT

Alanine aminotransferase

IFCC with pyridoxal phosphate

684Original formulation

IFCC5 (2002), manual

measurement

1.94

116

0.0153

0.917

µkat/L

U/L

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

ALT

Alanine aminotransferase

IFCC without pyridoxal phosphate

685Original formulation

IFCC5 (2002) modified,

manual measurement

1.94

116

0.0153

0.917

µkat/L

U/L

ALT

Alanine aminotransferase

IFCC without pyridoxal phosphate HiCo

176Original formulation

IFCC5 (2002) modified,

manual measurement

1.94

116

0.0153

0.917

µkat/L

U/L

AMY-L

Amylase alpha

IFCC liquid

570Roche reagent according

to IFCC5 (1998), manual

measurement

2.94

176

0.0261

1.56

µkat/L

U/L

AMY-L

Amylase alpha

IFCC liquid STAT

566Roche reagent according

to IFCC5 (1998), manual

measurement

2.94

176

0.0261

1.56

µkat/L

U/L

P-AMY

Amylase alpha pancreatic

ESP liquid

571Roche reagent, manual

measurement

1.57

94.0

0.0105

0.628

µkat/L

U/L

APOAT

Apolipoprotein A-I

immunoturbidimetric ver. 2

168WHO international

reference material

SP1-01

144

1.44

4.24

0.0424

mg/dL

g/L

APOALApolipoprotein A-I

immunoturbidimetric ver. 2

436WHO international reference material

SP1-01

1441.44

4.240.0424

mg/dLg/L

APOBTApoliprotein B

immunoturbidimetric ver. 2

151WHO international reference material

SP3-07

61.50.615

4.700.0470

mg/dLg/L

APOBLApoliprotein B

immunoturbidimetric ver. 2

199WHO international reference material

SP3-07

61.50.615

4.700.0470

mg/dLg/L

ASLOAntistreptolysin 0

immunoturbidimetric

037Internal standard material

248 2.92 IU/mL

AST

Aspartate aminotransferaseIFCC with pyridoxal phosphate

686Original formulation

IFCC5 (2002), manual

measurement

2.27

136

0.0163

0.979

µkat/L

U/L

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

AST

Aspartate aminotransferase

IFCC without pyridoxal phosphate

687Original formulation

IFCC5 (2002) modified,

manual measurement

2.27

136

0.0163

0.979

µkat/L

U/L

BILD2

Bilirubin direct

Diazo Gen. 2Jendrassik-Grof

734Roche reagent, manual

measurement(Jendrassik-Grof)

2.16

37.0

0.0153

0.262

mg/dL

µmol/L

BILD2Bilirubin direct

Diazo Gen. 2 Doumas

727Roche reagent, manual measurement

(Doumas)

1.8431.5

0.01300.223

mg/dL µmol/L

TBILIBilirubin total

liquid STAT

018acc. to Doumas 3.80

65.00.08541.46

mg/dLµmol/L

BILT3Bilirubin total

DPD Gen. 3

712 acc. to Doumas 3.8265.3

0.05650.966

mg/dLµmol/L

BUN Blood urea nitrogen

kinetic UV

421 ID-MS4 66.123.6

1.280.456

mg/dLmmol/L

BUN

Blood urea nitrogenkinetic UV STAT

427 ID-MS4 66.1

23.6

1.28

0.456

mg/dL

mmol/L

Ca

Calcium o-cresolphthaleine complexone

726 SRM 956c L33 13.4

3.34

0.0838

0.0209

mg/dL

mmol/L

Ca

Calcium o-cresolphthaleine complexone STAT

706 SRM 956c L33 13.4

3.34

0.0838

0.0209

mg/dL

mmol/L

Ca2

Calcium nM-BAPTA

698 SRM 956c L23 13.5

3.36

0.158

0.0394

mg/dL

mmol/L

Ca2

Calcium

nM-BAPTA STAT

699 SRM 956c L23 13.5

3.36

0.158

0.0394

mg/dL

mmol/L

C3C

Complement C3c

immunoturbidimetric

036 CRM 4702 149

1.49

1.26

0.0126

mg/dL

g/L

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

C4

Complement C4

immunoturbidimetric

032 ERM-DA470k/IFCC9 25.3

0.253

0.295

0.00295

mg/dL

g/L

CPLA2

Ceruloplasmin

immunoturbidimetric

709 CRM 4702 30.5

0.305

0.507

0.00507

mg/dL

g/L

CHECholinesterase

acethylthiocholine

725Roche reagent, manual measurement

51.43080

0.53832.2

µkat/LU/L

CHECholinesterase

butyrylthiocholine Gen.2

510Roche reagent, manual measurement

1026120

0.96958.0

µkat/LU/L

CHOLCholesterol

CHOD-PAP stand. ID/MS

433 ID-MS4 5.10 0.036510

mmol/L

CHOLCholesterol

CHOD-PAP stand. Abell-Kendall

433 Abell-Kendall 5.18 0.037110

mmol/L

CK

Creatine kinase IFCC liquid

057Original formulation

IFCC5 (2002), manual

measurement

4.99

299

0.0287

1.72

µkat/L

U/L

CK-MB

Creatine kinase-MBliquid

060Original formulation

IFCC5 (2002) modified,

manual measurement

1.26

75.7

0.0187

1.12

µkat/L

U/L

CREA

Creatinine

plus

652 ID-MS4 3.73

330

0.0314

2.78

mg/dL

µmol/L

CREA

Creatinine

Jaffé compensated STAT

773 ID-MS4 3.86

342

0.0571

5.05

mg/dL

µmol/L

CREACreatinine

Jaffé rate-blanked and compensated

690 ID-MS4 4.16368

0.04904.34

mg/dLµmol/L

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

CRPL3

C-Reactive Protein

immunoturbidimetric Gen. 3

Mod P: 210Mod D: 200

CRM 4702

32.9

3.29

313

0.664

0.0664

6.32

mg/L

mg/dL

nmol/L

Fe

Iron

FerroZine

661 SRM 9373 231

41.3

2.72

0.486

µg/dL

µmol/L

Ferr4Ferritin

particle enhanced test Gen. 4

692NIBSC

8Reagent Ferritin

(human liver) 08/602199447

2.285.12

µg/Lpmol/L

GGT

Glutamyltransferase gamma

liquid stand. Szasz

479Original formulation

Persijn/v.d. Slik (1976),

manual measurement

3.41

204

0.0473

2.83

µkat/L

U/L

GGTGlutamyltransferase gamma

liquid stand. Szasz HiCo

480Original formulation Persijn/v.d. Slik (1976),

manual measurement

3.41204

0.04732.83

µkat/LU/L

GGTGlutamyltransferase gamma

liquid stand. IFCC

219Original formulation IFCC

5 (2002), manual

measurement

3.86231

0.06103.65

µkat/LU/L

GGTGlutamyltransferase gamma

liquid stand. IFCC HiCo

220Original formulation IFCC

5 (2002), manual

measurement

3.86231

0.06103.65

µkat/LU/L

GLDHGlutamate dehydrogenase

opt. (DGKC)

588Roche reagent, manual measurement

0.67140.2

0.01040.622

µkat/LU/L

GLU

Glucose GOD-PAP

525 ID-MS4 229

12.7

2.61

0.145

mg/dL

mmol/L

GLU

Glucose HK

668 ID-MS4 229

12.7

2.61

0.145

mg/dL

mmol/L

GLU

Glucose HK STAT

767 ID-MS4 229

12.7

2.61

0.145

mg/dL

mmol/L

GLUH2

Glucose hemolysate Gen. 2

409 ID-MS4 229

12.7

2.61

0.145

mg/dL

mmol/L

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

HBDH

Hydroxybutyrate dehydrogenase

alphaopt. (DGKC)

567Roche reagent, manual

measurement

5.03

301

0.0705

4.22

µkat/L

U/L

HDLC3

HDL-Cholesterolplus 3

rd generation

435

According to the CDC7

referencemethod [Precipitation by

dextran

sulphate and Abell-Kendall]

1.49 0.0399 mmol/L

HGLOB

Haptoglobin

immunoturbidimetric

228 ERM-DA470k/IFCC9 119

1.19

1.63

0.0163

mg/dL

g/L

IGA-2

Immunoglobulin A

immunoturbidimetric Gen.2 standard

458 CRM 4702

2.29 0.027111

g/L

IGG-2

Immunoglobulin G

immunoturbidimetric Gen.2 standard

674 ERM-DA470k/IFCC9 1160

11.6

8.88

0.0888

mg/dL

g/L

IGM-2Immunoglobulin M

immunoturbidimetric Gen.2 standard

465 CRM 4702

1.01 0.015011

g/L

KAPPAKappa

immunoturbidimetric

283CRM 470

2

(calculated over Lievens

equation)

3233.23

4,390.0439

mg/dLg/L

LAC

Lactateenzymatic colorimetric test

040Primary reference

material (weighed in purified material)

3.63 0.0264 mmol/L

LAMBD

Lambdaimmunoturbidimetric

284CRM 470

2

(calculated over Lievens equation)

177

1.77

2.51

0.0251

mg/dL

g/L

LDH

Lactate dehydrogenase IFCC liquid

080Original formulation

IFCC5 (2002), manual

measurement

5.06

303

0.0357

2.14

µkat/L

U/L

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

LDH

Lactate dehydrogenase

IFCC liquid with automatic sample pre-dilution

147Original formulation

IFCC5 (2002), manual

measurement

5.06

303

0.0357

2.14

µkat/L

U/L

LDH

Lactate dehydrogenaseopt.(DGKC)

672Roche reagent, manual

measurement

9.67

579

0.106

6.35

µkat/L

U/L

LDLC2

LDL-Cholesterol

plus 2nd generation

059

According to CDC7beta

quantificationmethod [Precipitation by heparinmanganese(ultracentrifugation) and

Abell-Kendall]

2.60 0.0421 mmol/L

LIP

Lipase

enzymatic colorimetric test

731Roche reagent, manual

measurement

1.58

94.4

0.0169

1.01

µkat/L

U/L

LIP

Lipase

enzymatic colorimetric test STAT

733Roche reagent, manual

measurement

1.58

94.4

0.0169

1.01

µkat/L

U/L

MG

Magnesium

xylidyl blue method

693 Atomic absorption1.32

3.21

0.00646

0.0157

mmol/L

mg/dL

MGMagnesium

xylidyl blue method STAT

770 Atomic absorption1.323.21

0.006460.0157

mmol/Lmg/dL

PALB2Prealbumin

immunoturbidimetric

710ERM-DA470k/IFCC

9

27.80.278

0.4170.00417

mg/dLg/L

PALBLPrealbumin

immunoturbidimetric

546ERM-DA470k/IFCC

9

27.80.278

0.4170.00417

mg/dLg/L

PHOSPhosphate (inorganic)

molybdate UV

714

Primary reference material (NERL)

(weighed in purified

material)

6.202.00

0.05830.0188

mg/dLmmol/L

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

Routine Method

Hitachi SystemsACN Reference Method Reference Material

Selected Measurement

ProcedureAssigned Value Uncertainty 1 Unit

PHOS

Phosphate (inorganic)

molybdate UV STAT

675

Primary reference

material (NERL)

(weighed in purified material)

6.20

2.00

0.0583

0.0188

mg/dL

mmol/L

TRSF2

Transferinimmunoturbidimetric

Mod P: 187Mod D: 231

CRM 4702

3.37

337

0.0462

4.62

g/L

mg/dL

TG

Triglycerides

GPO-PAP

781 ID-MS4 2.47 0.0278 mmol/L

TG

Triglycerides

GPO-PAP GB

783 SRM 909b 349.6

0.560

0.735

0.00830

mg/dL

mmol/L

TP

Total protein

Biuret

678 SRM 927d 37.65

76.5

0.0516

0.516

g/dL

g/L

TP

Total protein

Biuret STAT

679 SRM 927d 37.65

76.5

0.0516

0.516

g/dL

g/L

UAUric acid

plus

700 ID-MS4 12.1722

0.05583.32

mg/dLµmol/L

UREAUrea

kinetiv UV

418 ID-MS4 14223.6

2.740.456

mg/dLmmol/L

UREAUrea

kinetiv UV STAT

419 ID-MS4 14223.6

2.740.456

mg/dLmmol/L

1 This uncertainty (expanded uncertainty; k = 2) was calculated in accordance with the “Guide to the expression of uncertainty in measurement” (GUM: 1993). For the estimation of the single standard uncertainties normal distribution of the measurement results is assumed; the level of confidence of the expanded uncertainty is about 95% with the coverage factor k=2 (analogue to the 2sd of the standard uncertainty).

2 CRM = Certified Reference Material, European3 SRM = Standard Reference Material4 ID-MS = Isotope Dilution - Mass Spectrometry5 IFCC = International Federation of clinical chemistry and laboratory medicine

TRACEABILITY and UNCERTAINTY Hitachi - PreciControl® ClinChem Multi 2

Cat. No. 05 947 774 190, 05 117 216 190, 05 117 291 922 (Q.C.S.)

Roche Diagnostics GmbH März 2018

6 WHO = World Health Organisation7 CDC = Centre for Disease Control8 NIBSC = National Institute for Biological Standards and Control9 ERM-DA470k/IFCC = European Reference Materials10 The value describes the uncertainty within a system class. By transferring the setpoint from one system class to another an additional systematic deviation can arise. This deviation

is limited by the instrument to instrument specification. The relative maximum deviation is 5 %, resp. CHOL 0.1 mmol/L.11 The value describes the uncertainty within a system class. By transferring the setpoint from one system class to another an additional systematic deviation can arise. This deviation

is limited by the instrument to instrument specification. The relative maximum deviation is 10 %, resp. 0.1 g/L IgA or 0.03 g/L IgM.